TITLE

Evaluation of the Optimal Oral Antihistamine for Patients With Allergic Rhinitis

AUTHOR(S)
Meltzer, Eli O.
PUB. DATE
September 2005
SOURCE
Mayo Clinic Proceedings;Sep2005, Vol. 80 Issue 9, p1170
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Because of its bothersome symptoms, allergic rhinitis (AR) is 1 of the top 10 reasons for patient visits to primary care physicians. This highly prevalent disease also results in loss of productivity, both at work and in school. Oral antihistamines are one of the most frequently prescribed medications for the management of AR and, with several agents available. It is important to discern the specific benefits and detriments of each. To assess the differences in efficacy and safety factors among antihistamines, the individual therapeutic window of each agent can be used as a comparative reference tool because it defines the dose range over which an antihistamine is efficacious and free of adverse effects. As such, the therapeutic window includes both undesired effects, such as sedation, and desired properties, such as rapid onset of action, long duration of efficacy, broad age range of applicability, and potential to improve quality of life. Therefore, agents with broad therapeutic windows, based on both efficacy and safety, are expected to be more favorable; this therapeutic window should be understood by the primary care physician when prescribing a medication.
ACCESSION #
18184312

 

Related Articles

  • Efficacy and Safety of Azelastine and Levocetirizine in Allergic Rhinitis. Mahajan, Surbhi; Gupta, Vipan; Gupta, Ashwani K.; Matreja, Prithpal S.; Singh, Amandeep; Khanna, P. M. L.; Singh, Sunder // Journal of Pakistan Medical Students;Jul-Sep2013, Vol. 3 Issue 3, p143 

    BACKGROUND: Allergic rhinitis is an inflammatory disease with worldwide prevalence of 10-40%. Clinically, the condition manifests as nasal itching (pruritus), sneezing, rhinorrhea, congestion and itchy eyes. The second generation antihistamines are commonly used either as nasal sprays...

  • Triamcinolone Nasal Spray.  // AHFS Consumer Medication Information;May2017, p1 

    Triamcinolone nasal spray is used to treat symptoms of seasonal (occurs only at certain times of year), and perennial (occurs all year round) allergic rhinitis and perennial nonallergic rhinitis. These symptoms include sneezing and stuffy, runny, or itchy nose. Triamcinolone is in a class of...

  • Montelukast: Pharmacology, Safety, Tolerability and Efficacy. Benninger, Michael S.; Waters, Heather // Clinical Medicine: Therapeutics;2009, Issue 1, p1253 

    Allergic rhinitis and asthma are common disorders effecting large percentages of the population of Western countries. There are multiple treatment options available for allergic rhinitis and asthma and stepwise approaches to therapy have been recommended. Montelukast is a cysteinyl leukotriene...

  • Incidence of allergic rhinitis increases by a third in five years.  // Nursing Standard;11/12/2008, Vol. 23 Issue 10, p17 

    The article reports on the result of the study which examined the trends in the recorded incidence, lifetime prevalence and prescribing of symptom relief medication for allergic rhinitis in England. According to the study, the recorded incidence and lifetime prevalence of allergic rhinitis has...

  • NOTHING TO SNEEZE AT. Crackel, Laura // Overdrive;Mar2005, Vol. 45 Issue 3, p22 

    Discusses the various medications suitable for drivers suffering from hay fever. Warning against the possible symptoms of sniffling, sneezing and watery eyes from pollen and seasonal allergens; Antihistamines; Nasal decongestants; Nasal corticosteroids; Eye drops; Saline nose drops.

  • Reasons for prescribing second generation antihistamines to treat allergic rhinitis in real-life conditions and patient response. Demoly, Pascal; Chiriac, Anca Mirela; Berge, Benoît; Rostin, Michel // Allergy, Asthma & Clinical Immunology;2014, Vol. 10 Issue 1, p1 

    Background Second generation H1 antihistamines (H1A) are currently recommended as first choice medications for allergic rhinitis and rhinoconjunctivitis. However, little is known about what influences the choice of prescription of one second generation (H1A) as opposed to another in real-life...

  • Immunity from Allergies. Hallowell, Christopher L. // Sciences;Nov75, Vol. 15 Issue 8, p11 

    Focuses on treatments on allergies in the United States. Characteristics of hay fever; Effectiveness of antihistamines and epinephrine in treating allergic reactions; Introduction to the methods of immunotherapy; Information on the nature of antibodies responsible for allergy.

  • Efficacy and Tolerability Comparison of Ebastine 10 and 20mg with Loratadine 10mg: A Double-Blind, Randomised Study in Patients with Perennial Allergic Rhinitis. Davies, R.J. // Clinical Drug Investigation;1998, Vol. 16 Issue 6, p413 

    Objective: To compare the dose-related efficacy and tolerability of the oral H antihistamine ebastine (10 or 20mg) with a reference drug, loratadine (10mg), in the once-daily treatment of perennial allergic rhinitis (PAR). Patients and Methods: The trial was conducted in 317 patients (aged 12 to...

  • Rupatadine: pharmacological profile and its use in the treatment of allergic rhinitis. Rao, M. Sudhakara; Reddy, D. Dwarakanatha; Murthy, P. S. N. // Indian Journal of Otolaryngology & Head & Neck Surgery;Oct-Dec2009, Vol. 61 Issue 4, p320 

    Rupatadine is a once-daily, non-sedating, selective and long-acting new drug with a strong antagonist activity towards both histamine HI receptors and platelet-activating factor receptors. The use of rupatadine is indicated in adult and adolescent patients (> 12 years of age) suffering from...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics